Literature DB >> 6896037

Lectin agglutinability of mammary tumours with differing metastatic colonisation potentials.

J E Price, D Tarin.   

Abstract

A new fully quantitative method for assessment of lectin agglutinability has been used in this investigation to compare the surface composition of cells from tumours with high and low pulmonary colonisation potential. As in our previous work, we have used only primary (i.e., naturally-occurring) mammary tumours in mice. It was found that agglutinability with the lectins Concanavalin-A and Wheatgerm agglutinin bore no relationship to the pulmonary colonisation potential of the primary mammary tumour. However, cells from disaggregated secondary deposits of tumours which manifested high colonisation potential were consistently less agglutinable than the cells of the primary tumours from which they were derived.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6896037     DOI: 10.1111/j.1432-0436.1981.tb01182.x

Source DB:  PubMed          Journal:  Differentiation        ISSN: 0301-4681            Impact factor:   3.880


  5 in total

Review 1.  Tumor cell surface carbohydrate and the metastatic phenotype.

Authors:  J W Dennis; S Laferte
Journal:  Cancer Metastasis Rev       Date:  1987       Impact factor: 9.264

Review 2.  Intratumor immunologic heterogeneity.

Authors:  F R Miller
Journal:  Cancer Metastasis Rev       Date:  1982       Impact factor: 9.264

3.  Investigations of the mechanisms of metastatic spread of naturally occurring neoplasms.

Authors:  D Tarin
Journal:  Cancer Metastasis Rev       Date:  1982       Impact factor: 9.264

4.  Differences in surface expression of WGA-binding proteins of cells from a lymphosarcoma and its liver metastases.

Authors:  W S Chan; A Jackson; G A Turner
Journal:  Br J Cancer       Date:  1984-02       Impact factor: 7.640

5.  Effect of enzymic removal of cell surface constituents on metastatic colonisation potential of mouse mammary tumour cells.

Authors:  N S Sargent; J E Price; D Tarin
Journal:  Br J Cancer       Date:  1983-10       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.